Canine Arthritis Treatment Market

Name: Canine Arthritis Treatment Market
Brand: Future Market Insights
SKU: Healthcare, Pharmaceuticals and Medical devices
Price: 5000 USD
Availability: InStock
Rating: 3.5 (36 reviews)

Canine Arthritis Treatment Market: Ease in Regulatory Approvals Reigniting Growth Opportunities: Global Industry Analysis, 2014 - 2018 and Opportunity Assessment, 2019 - 2029

2019-10-21
REP-GB-3552
28 Tables
78 Figures
183 pages

Home
Market Research Reports
Healthcare, Pharmaceuticals and Medical devices
Canine Arthritis Treatment Market

An Incisive, In-depth Analysis on the Canine Arthritis Market

This study offers a comprehensive, 360 degree analysis on the Canine Arthritis market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Canine Arthritis market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Request a sample

Ask An Analyst

Request Special Price

Request Methodology

COVID -19 : Impact Analysis

Request the coronavirus imapact analysis across industries and markets

Request Covid -19 Impact

Canine Arthritis Treatment Market - Key Research Findings

canine arthritis treatment market snapshot

The global canine arthritis treatment market in 2019 is estimated to reach a value of ~ US$ 1.9 Bn.
The canine arthritis treatment market is expected to grow at a CAGR of ~ 4% during the forecast period of 2019-2029.
Increasing prevalence of obesity associated with arthritis, rising adoption rate of canines, growing awareness of the pet-related diseases, high disposable income, and ease in the regulatory approvals for innovative drugs have been driving factors for the growth of the canine arthritis treatment market.
Collectively, Europe and North America, are expected to account for half of the revenue shares in the canine arthritis treatment market by the end of 2029.
- North America will continue to be a prominent regional market for canine arthritis treatment, due to increasing prevalence of arthritis, consumer spending on vet, awareness of diseases, and accessibility of treatment and diagnostic methods.
Non-steroidal anti-inflammatory medication remains the most preferred option for treatment. Non-steroidal anti-inflammatory medication is being used as a first choice of treatment for inflammatory diseases by veterinary physician, as it has better anti-inflammatory action, safety profile, and fast onset of action. Opioids therapy is further likely to gain significant momentum over the forecast period.
- Increase in the number of non-steroidal anti-inflammatory drugs and use of stem cell therapies for canine arthritis treatment will continue to contribute to the market growth.
Oral medication has been increasingly used for canine arthritis treatment, due to its ease to use and better animal compliance. Greater availability of medications in oral formulations is likely to result in increased share in the canine arthritis treatment market.

Key Factors Shaping the Canine Arthritis Treatment Market

Launch of Veterinary Regenerative Medicines for Canine Arthritis Treatment

Fast FDA approvals for veterinary therapeutic drugs and veterinary regenerative medicines to repair diseased/damaged tissues and organs in animals are contributing to the growth of the canine arthritis treatment market. While veterinary drugs for canine arthritis treatment continue to account for higher sales, veterinary regenerative medicines prove to be an interesting area of research and development for developing novel therapies, such as stem cell therapy.
High Adoption of Allogeneic Stem Cell Therapy

There is an increase in number of allogeneic stem cell therapy for canine arthritis treatment, due to its higher success rate coupled with 100% safe therapy with better outcomes.
Direct Customer Interaction Facilitating Revenue Generation

Animal healthcare product manufacturers mainly rely on direct sales force to gain better access to distribution channels. Through this method, companies also seek to raise awareness, provide training, and support in areas of disease management and adherence to treatment protocols. In this regard, Zoetis directly sells its products to a variety of distribution channels such as veterinarians, third-party veterinary distributors, and also major retail pharmacies, veterinary clinics & hospitals.

Growth of Canine Arthritis Treatment Market in Developing Economies

An increase in investment in the animal healthcare domain, rapid development of animal healthcare infrastructure, and increasing prevalence of canine arthritis in the Asia Pacific region are factors offering a strong impetus to the growth of the canine arthritis treatment market. The launch of better therapeutic drugs prominently accounts for the growing popularity of canine arthritis treatment across developing regional markets. Consistent rise in the number of manufacturers and distributors, is likely to contribute to the growth of the canine arthritis treatment market in the near future.

global canine arthritis treatment market

Canine Arthritis Treatment Competition Analysis

Key players in the canine arthritis market continue to increase their share with the launch of new products.
Joint ventures and partnership with distributors are the strategic actions practised by majority of key players.
Prominent players continue to address the unmet needs in the market through inorganic strategies, such as mergers and acquisitions.
The canine arthritis treatment market has been relatively moderate in size and likely to remain dynamic, growing in steady pace throughout the forecast period.
Major players focus on inorganic growth strategies to make a strong hold on targeted in-licensing and acquisitions through expanding their R&D activities and distribution channels, particularly including specialist retail chains.

Canine Arthritis Treatment Analysis 2019-2029

A recent market study published by Future Market Insights (FMI) on the canine arthritis treatment including global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the canine arthritis treatment, the growth prospects of the market are obtained with maximum precision.

Canine Arthritis Treatment: Segmentation

The global canine arthritis treatment is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Treatment	Route of Administration	Distribution Channel	Region
Non-steroidal anti-inflammatory Medications (NSAIDs) Opioids Stem Cell Therapy Allogeneic Stem Cells Autologous Stem Cells	Oral Injectable	Veterinary Hospitals & Clinics Retail Pharmacies Drug Stores E-Commerce	North America Latin America Europe Asia Pacific excluding Japan Japan Middle East & Africa

Report Chapters

Chapter 01 – Executive Summary

The report initiates with the executive summary of the canine arthritis treatment, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the canine arthritis treatment.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the canine arthritis treatment in this chapter, which will help them understand the basic information about the canine arthritis treatment.

Chapter 03 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the canine arthritis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 04 – Market Context

This section includes premium insights such as regulatory scenario, disease epidemiology, industry view point and market evolution. This section helps readers understand the key factors associated with the canine arthritis treatment market.

Chapter 05 – Global Canine Arthritis Treatment Value Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the Canine Arthritis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical canine arthritis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Treatment

Based on treatment type, the canine arthritis treatment market is segmented into Non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell therapy. In this chapter, readers can find information about the key trends and developments in the canine arthritis treatment and market attractiveness analysis based on treatment.

Chapter 07 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Route of Administration

This chapter provides details about the canine arthritis treatment based on mode of administration, and has been classified into oral and injectable. In this chapter, readers can understand the market attractiveness analysis based on route of administration.

Chapter 08 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel

This chapter provides details about the canine arthritis treatment market based on distribution channel, and has been classified into veterinary hospitals and clinics, retail pharmacies, drug stores, and E-Commerce. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 09 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the canine arthritis treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 10 – North America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America canine arthritis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.

Chapter 11 – Latin America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the canine arthritis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 12 – Europe Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the canine arthritis treatment market based on its Distribution Channels in several countries such as Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.

Chapter 13 – Asia Pacific Excluding Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in the APEJ region.

Chapter 14 – Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in Japan.

Chapter 15 – MEA Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the canine arthritis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 16 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the canine arthritis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Elanco, Zoetis, Bayer, VetStem Biopharma and among others.

Chapter 17 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the canine arthritis treatment report.

Chapter 18 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about The Canine Arthritis Treatment.

Sources and Primary Research Splits (%)

Industry Interactions